Chemours Stock Rating (CC) Down by JPMorgan Chase & Company

Chemours Stock Rating (CC) Down by JPMorgan Chase & Company
Chemours (NYSE: CC) was downgraded by research analysts of JP Morgan Chase & Co., from the "flyweight" rating to Monday, the "Neutral" rating was given in the research reports issued to clients and investors.

CC has been the subject of many other reports. HSBC started reporting Chemore shares in a research note on Tuesday, January 8. He released the "Buy" rating for the company and the target price of $ 52.00. Barclays reiterated the "purchase" rating of $ 48.00 and determined the price of Chemore shares in the research report on Tuesday 15 January. Susquehanna Bancshares confirmed its "neutral" rating and set a target price of $ 37.00 in Chemour's shares in a research report on Tuesday, 19 February. SunTrust Banks has targeted the price of the Kemiro stock at $ 40.00 and on Tuesday 19 February the "Hold" rating on the research report. Finally, Citigroup confirmed the "purchase" rating and set a target price of $ 43.00 in Chemore's stock in a research report on Wednesday, February 20th. An investment analyst has assessed the stock with the sales rating, four have issued a detention rating, and seven have set a buy rating for the company's shares. Chemours currently has a "buy" average rating and a consensus target value of $ 49.63.

NYSE CC opened on Monday at $ 34.18. The company has a sharp proportion of 1.26, the current ratio of 1.93 and a debt of 3.88 ratios. The company has a market capitalization of $ 5.68 billion, the cost-to-profit ratio of 6.03, the value-to-income-increase ratio of 0.49 and the beta of 2.20. Camero has $ 25.17 for 12 months and $ 53.25 for a 12-month high.

Chemours (NYSE: CC) released final results on Thursday, May 2 Special Chemical Companies reported revenue of $ 0.63 per share (EPS) for the quarter, loses the consensus estimate of Jokes' $ 0.93 ($ 0.30). During the quarter, the revenue of $ 1.38 billion in revenues was estimated at an estimated $ 1.52 billion analyst. The net margin of Kemaro is at 14.99% and the return is 98.83% equity. Camaro's revenues decreased by 20.5% compared to the same quarter last year. During the same quarter of last year, the company had earned $ 1.41 per share. As a group, analysts estimate that Chemors will post 4.52 EPS for the current fiscal year.

In other news, Paul Kirsh's insider sold 10,000 shares of a company on February 25, in a transaction on Monday. Shares are sold at an average price of $ 38.66 with an average value of $ 38.66. This transaction has been disclosed to the SEC, which is available on this link. In addition, VP Amy Trojanowski sold 13,536 shares of the company in a transaction on Friday, March 1. The stock was sold at an average price of $ 38.63, in which the total transaction was $ 522,895.68. After the sale is completed, the current vice president is directly owned by 54,367 shares in the company, which is worth approximately $ 2,100,197.21. The disclosures for this sale can be found here. Insiders have sold a total of 101,924 shares of the company in the last three months for $ 3,924,730. 2.34% of the company's shares are with Insider.

Some institutional investors and hedge funds have recently bought and sold CC shares. Arora Investment Council raised the status of Camero by 11.9% during the fourth quarter. Aurora Investment Council now has 58,798 shares of a special chemical company, during which its price is $ 1,659,000 after buying 6,257 additional shares. The LP Dimension Fund Adviser has increased the status of Camero to 2.9% during the 4th quarter. Dimensional fund consultant, LP now has 989719 shares of a special chemical company's stock, during which 27,651 shares are worth 27,929,000 dollars after purchasing additional shares. FUKOKU MUTUAL LIFE INSURANCE Co. In the fourth quarter, Chemours raised its position by 357.1%. FUKOKU MUTUAL LIFE INSURANCE CO. After the acquisition of 2,500 additional shares, the shares of a special chemical company are now valued at $ 90,000. Piedmont Investment Advisors Inc. increased the shares of Shawom in the 4th quarter to 31.4%. Piedmont Investment Advisors Inc. Now after receiving 4,042 additional shares during this period, there are 16,930 shares of a special chemical company worth $ 478,000. Finally, HRT Financial LLC acquired new shares in Chemors' shares in the fourth quarter, which was valued at approximately $ 908,000. Currently, institutional investors and hedge funds have 81.37% shares.

Chemours Company Profile

Chemours Company offers high-performance chemicals in North America, Asia Pacific, Europe, Middle East, Africa, and Latin America.

Post a Comment